<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00812617</url>
  </required_header>
  <id_info>
    <org_study_id>eki-77</org_study_id>
    <nct_id>NCT00812617</nct_id>
  </id_info>
  <brief_title>Effects of Mineral Water Consumption on Serum Lipid Parameters</brief_title>
  <official_title>Effects of Mineral Water Consumption on Serum Lipid Parameters: a Double-Blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hiroshima University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hita Tenryosui Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hiroshima University</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the effect of a specific mineral water on serum
      lipid concentrations in healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting total cholesterol, LDL cholesterol, and triglyceride levels</measure>
    <time_frame>Every 4 weeks (Overall 20 weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting serum glucose and HbA1c levels</measure>
    <time_frame>Every 4 weeks (Overall 20 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum uric acid level</measure>
    <time_frame>Every 4 weeks (Overall 20 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum adiponectin and leptin levels</measure>
    <time_frame>Week 0, Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary oxidative stress marker</measure>
    <time_frame>Week 0, Week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Mineral water 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mineral water 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mineral water (Hita, Oita, Japan)</intervention_name>
    <arm_group_label>Mineral water 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mineral water (Aso-gun, Kumamoto, Japan)</intervention_name>
    <arm_group_label>Mineral water 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy as based on medical history and physical examination

          -  Fasting serum LDL cholesterol &gt; 100 and/or fasting serum triglyceride &gt; 100

          -  Willing to drink mineral water for 12 weeks

          -  Willing not to serve as blood donor during the study

          -  Informed consent signed

        Exclusion Criteria:

          -  Female subjects who are pregnant or nursing a child

          -  Participation in any clinical trial up to 90 days before Day 01 of this study

          -  Renal or hepatic dysfunction

          -  Heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fumiko Higashikawa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hiroshima University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hiroshima University</name>
      <address>
        <city>Hiroshima</city>
        <zip>734-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2008</study_first_submitted>
  <study_first_submitted_qc>December 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2008</study_first_posted>
  <last_update_submitted>October 5, 2009</last_update_submitted>
  <last_update_submitted_qc>October 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Fumiko higashikawa</name_title>
    <organization>Hiroshima University</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

